AIDS Healthcare Foundation (AHF) today criticized efforts to introduce federal legislation to address drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies. It said the drug industry “will certainly use any legislation as an opportunity to further undermine” the 340B program.
AHF announced its opposition in a statement to 340B Report. It comes on the heels of the National Association of Community Health Centers (NACHC) and hospital group 340B Health’s recent statements that it might be up to Congress to quash drug manufacturers’ conditions on 340B pricing involving contract pharmacy.
AIDS Healthcare Foundation (AHF) today criticized efforts to introduce federal legislation to address drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies. It said the drug industry “will certainly use any legislation as an opportunity to further undermine” the 340B program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
